|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.08 USD | +2.39% |
|
-1.16% | +3.31% |
| Jan. 15 | Henry Schein enters distribution agreement for CytoChip's CLIA-waived hematology analyzer | RE |
| Jan. 15 | Henry Schein Agrees to Distribute CytoChip's CitoCBC system | MT |
Company Valuation: Henry Schein, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 9,455 | 10,660 | 10,771 | 9,883 | 8,780 | 9,192 | 9,192 | - |
| Change | - | 12.75% | 1.04% | -8.24% | -11.16% | 4.69% | 0% | - |
| Enterprise Value (EV) 1 | 9,732 | 11,414 | 11,803 | 12,063 | 11,194 | 12,139 | 11,760 | 11,425 |
| Change | - | 17.28% | 3.4% | 2.21% | -7.2% | 8.44% | -3.13% | -2.84% |
| P/E ratio | 23.5x | 17.3x | 20.3x | 24.1x | 23.1x | 23x | 18.5x | 17x |
| PBR | 2.82x | 3.08x | 3.04x | 2.69x | 2.58x | 2.42x | 2.13x | 1.87x |
| PEG | - | 0.3x | -1.7x | -1.3x | -6.64x | 2x | 0.8x | 1.9x |
| Capitalization / Revenue | 0.93x | 0.86x | 0.85x | 0.8x | 0.69x | 0.7x | 0.68x | 0.65x |
| EV / Revenue | 0.96x | 0.92x | 0.93x | 0.98x | 0.88x | 0.93x | 0.87x | 0.81x |
| EV / EBITDA | 12.9x | 10.7x | 12.3x | 12.3x | 10.6x | 11x | 10.2x | 9.42x |
| EV / EBIT | 17.2x | 13.3x | 15.8x | 19.6x | 11.8x | 12.6x | 11.6x | 10.7x |
| EV / FCF | 17.7x | 18.1x | 23.3x | 34.2x | 16x | 30.2x | 18.8x | 16.4x |
| FCF Yield | 5.65% | 5.52% | 4.29% | 2.93% | 6.25% | 3.31% | 5.31% | 6.08% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.82 | 4.45 | 3.91 | 3.16 | 3.05 | 3.393 | 4.215 | 4.592 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 10,119 | 12,401 | 12,647 | 12,339 | 12,673 | 13,084 | 13,526 | 14,047 |
| EBITDA 1 | 752.9 | 1,069 | 959 | 984 | 1,061 | 1,100 | 1,153 | 1,213 |
| EBIT 1 | 567.4 | 859.6 | 747 | 615 | 949 | 964.6 | 1,013 | 1,066 |
| Net income 1 | 403.8 | 631.2 | 538 | 416 | 390 | 416 | 492.1 | 528.6 |
| Net Debt 1 | 277.8 | 754.6 | 1,032 | 2,180 | 2,414 | 2,947 | 2,568 | 2,233 |
| Reference price 2 | 66.22 | 76.87 | 79.46 | 76.06 | 70.42 | 78.08 | 78.08 | 78.08 |
| Nbr of stocks (in thousands) | 142,776 | 138,674 | 135,548 | 129,938 | 124,681 | 117,725 | 117,725 | - |
| Announcement Date | 2/17/21 | 2/15/22 | 2/16/23 | 2/27/24 | 2/25/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 23.01x | 0.93x | 11.04x | -.--% | 9.19B | ||
| 15.59x | 0.3x | 6.38x | 2.25% | 1.58B | ||
| 19.42x | 1.41x | 10.72x | 2.53% | 1.11B | ||
| Average | 19.34x | 0.88x | 9.38x | 1.59% | 3.96B | |
| Weighted average by Cap. | 21.69x | 0.89x | 10.39x | 0.54% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- HSIC Stock
- Valuation Henry Schein, Inc.
Select your edition
All financial news and data tailored to specific country editions
















